To read the full story, subscribe or sign in.

Merck presents novel substituted piperidines as selective human MC4 receptor agonists

Feb. 2, 2001

BioWorld Science Nephrology Urology Patents

Today's news in brief

BioWorld

BioWorld briefs for May 26, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for May 26, 2026

Microscopy of a cross-section of mouse skin containing melanoma tumors

Researchers identify innate immune barrier against melanoma

BioWorld

Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...

Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers

BioWorld Science

Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...

MSD divulges new KLKB1 inhibitors

BioWorld Science

Merck Sharp & Dohme LLC (MSD) has reported new plasma kallikrein (KLKB1) inhibitors potentially useful for the treatment of diabetic macular edema, cancer,...